Cargando…
Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000
BACKGROUND: It is unclear whether individualized treatments based on biological factors have improved the prognosis of recurrent breast cancer. The purpose of this study is to evaluate the survival improvement of patients with recurrent breast cancer after the introduction of third generation aromat...
Autores principales: | Shigematsu, Hideo, Kawaguchi, Hidetoshi, Nakamura, Yoshiaki, Tanaka, Kimihiro, Shiotani, Satoko, Koga, Chinami, Nishimura, Sumiko, Taguchi, Kenichi, Nishiyama, Kenichi, Ohno, Shinji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080832/ https://www.ncbi.nlm.nih.gov/pubmed/21453503 http://dx.doi.org/10.1186/1471-2407-11-118 |
Ejemplares similares
-
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
por: Tokunaga, Eriko, et al.
Publicado: (2021) -
The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution
por: Tokunaga, Eriko, et al.
Publicado: (2020) -
CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Tokunaga, Eriko, et al.
Publicado: (2018) -
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
por: Tajiri, Wakako, et al.
Publicado: (2020) -
Programa académico 2000-2001 /
Publicado: (2000)